FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945986988> ?p ?o ?g. }

• W2945986988 endingPage "727" @default.
• W2945986988 startingPage "711" @default.
• W2945986988 abstract "Preeclampsia is a pregnancy-related syndrome of variable severity, classically characterized by acute kidney involvement, with hypertension and/or proteinuria and reduced kidney function. Once considered a self-limited disease healed by delivery, it is now acknowledged that preeclampsia can affect cardiovascular and kidney health in the long term. The entity of risk has not been established and consequently follow-up policies have not been defined. Here we undertook a systematic review to gain better insights into the need for post–preeclampsia follow-up. Articles published between January 2000 and March 2018 were selected, dealing with at least 20 preeclampsia patients, with follow-up of 4 years or more (MEDLINE, Embase, and Cochrane Library). No quality selection or language restriction was performed. Of the 10,510 titles and abstracts originally considered, 21 papers were selected, providing information on 110,803 cases with and 2,680,929 controls without preeclampsia, with partial overlap between studies on the same databases. Heterogeneity was high, and a random meta-analytic model selected. The increase in risk of end stage renal disease after preeclampsia was significant (meta-analytic risk ratios (95% confidence interval) 6.35 (2.73-14.79)); the risk of albuminuria and chronic kidney disease increased but statistical significance was not reached (4.31 (0.95-19.58) and 2.03 (0.58-7.32), respectively). Translating meta-analytic risk into the number of patients who need follow-up to detect one adverse event, 310 patients with preeclampsia are needed to identify one woman with end stage renal disease or four to identify one woman with albuminuria. Heterogeneity in definitions, insufficient follow-up and incomplete recruitment may account for discrepancies. Thus, preeclampsia significantly increases the risk of end stage renal disease. However, there is lack of sufficient data to show a relationship between preeclampsia, albuminuria and chronic kidney disease, underlining the need for further prospective studies. Preeclampsia is a pregnancy-related syndrome of variable severity, classically characterized by acute kidney involvement, with hypertension and/or proteinuria and reduced kidney function. Once considered a self-limited disease healed by delivery, it is now acknowledged that preeclampsia can affect cardiovascular and kidney health in the long term. The entity of risk has not been established and consequently follow-up policies have not been defined. Here we undertook a systematic review to gain better insights into the need for post–preeclampsia follow-up. Articles published between January 2000 and March 2018 were selected, dealing with at least 20 preeclampsia patients, with follow-up of 4 years or more (MEDLINE, Embase, and Cochrane Library). No quality selection or language restriction was performed. Of the 10,510 titles and abstracts originally considered, 21 papers were selected, providing information on 110,803 cases with and 2,680,929 controls without preeclampsia, with partial overlap between studies on the same databases. Heterogeneity was high, and a random meta-analytic model selected. The increase in risk of end stage renal disease after preeclampsia was significant (meta-analytic risk ratios (95% confidence interval) 6.35 (2.73-14.79)); the risk of albuminuria and chronic kidney disease increased but statistical significance was not reached (4.31 (0.95-19.58) and 2.03 (0.58-7.32), respectively). Translating meta-analytic risk into the number of patients who need follow-up to detect one adverse event, 310 patients with preeclampsia are needed to identify one woman with end stage renal disease or four to identify one woman with albuminuria. Heterogeneity in definitions, insufficient follow-up and incomplete recruitment may account for discrepancies. Thus, preeclampsia significantly increases the risk of end stage renal disease. However, there is lack of sufficient data to show a relationship between preeclampsia, albuminuria and chronic kidney disease, underlining the need for further prospective studies. Is preeclampsia a risk for end-stage renal disease?Kidney InternationalVol. 96Issue 3PreviewLittle information is available about the risk of end-stage renal disease (ESRD) after preeclampsia. The review of Covella et al. demonstrated that former preeclamptic women have a significant risk of ESRD in the medium term. However, it is still unknown which preeclamptic woman are at higher risk for progressive kidney disease. After delivery, women who had preeclampsia, particularly those with persistent hypertension, symptomatic proteinuria, or microalbuminuria, should receive a regular checkup for kidney disease. Full-Text PDF" @default.
• W2945986988 created "2019-05-29" @default.
• W2945986988 creator A5001391327 @default.
• W2945986988 creator A5017794721 @default.
• W2945986988 creator A5023916312 @default.
• W2945986988 creator A5044620585 @default.
• W2945986988 creator A5053878492 @default.
• W2945986988 creator A5086924377 @default.
• W2945986988 creator A5091162338 @default.
• W2945986988 date "2019-09-01" @default.
• W2945986988 modified "2023-10-17" @default.
• W2945986988 title "A systematic review and meta-analysis indicates long-term risk of chronic and end-stage kidney disease after preeclampsia" @default.
• W2945986988 cites W1145945895 @default.
• W2945986988 cites W1594609993 @default.
• W2945986988 cites W1745357917 @default.
• W2945986988 cites W1911361640 @default.
• W2945986988 cites W1966735563 @default.
• W2945986988 cites W1975280744 @default.
• W2945986988 cites W1979423827 @default.
• W2945986988 cites W1982900907 @default.
• W2945986988 cites W1997652121 @default.
• W2945986988 cites W2006089703 @default.
• W2945986988 cites W2008752479 @default.
• W2945986988 cites W2014923899 @default.
• W2945986988 cites W2015794890 @default.
• W2945986988 cites W2034488323 @default.
• W2945986988 cites W2036677302 @default.
• W2945986988 cites W2037920206 @default.
• W2945986988 cites W2047941878 @default.
• W2945986988 cites W2049879991 @default.
• W2945986988 cites W2051213492 @default.
• W2945986988 cites W2062456602 @default.
• W2945986988 cites W2063187079 @default.
• W2945986988 cites W2068305660 @default.
• W2945986988 cites W2071215485 @default.
• W2945986988 cites W2077421021 @default.
• W2945986988 cites W2095759878 @default.
• W2945986988 cites W2096853814 @default.
• W2945986988 cites W2097492425 @default.
• W2945986988 cites W2099332194 @default.
• W2945986988 cites W2103390263 @default.
• W2945986988 cites W2107328434 @default.
• W2945986988 cites W2110730662 @default.
• W2945986988 cites W2117794568 @default.
• W2945986988 cites W2126510193 @default.
• W2945986988 cites W2137020418 @default.
• W2945986988 cites W2145140833 @default.
• W2945986988 cites W2145547506 @default.
• W2945986988 cites W2150949422 @default.
• W2945986988 cites W215906235 @default.
• W2945986988 cites W2159121089 @default.
• W2945986988 cites W2159752579 @default.
• W2945986988 cites W2159990314 @default.
• W2945986988 cites W2161345057 @default.
• W2945986988 cites W2164315912 @default.
• W2945986988 cites W2173821285 @default.
• W2945986988 cites W2212762088 @default.
• W2945986988 cites W2233974801 @default.
• W2945986988 cites W2278319069 @default.
• W2945986988 cites W2324519287 @default.
• W2945986988 cites W2341276202 @default.
• W2945986988 cites W2510680768 @default.
• W2945986988 cites W2517024432 @default.
• W2945986988 cites W2544878647 @default.
• W2945986988 cites W2568775363 @default.
• W2945986988 cites W2588387346 @default.
• W2945986988 cites W2589164015 @default.
• W2945986988 cites W2755022538 @default.
• W2945986988 cites W2767317750 @default.
• W2945986988 cites W2777108378 @default.
• W2945986988 cites W2784288091 @default.
• W2945986988 cites W2789261481 @default.
• W2945986988 cites W2795927961 @default.
• W2945986988 cites W2796659748 @default.
• W2945986988 cites W2800413729 @default.
• W2945986988 cites W2800823741 @default.
• W2945986988 cites W2803978032 @default.
• W2945986988 cites W2804358556 @default.
• W2945986988 cites W2804462245 @default.
• W2945986988 cites W2804507112 @default.
• W2945986988 cites W2808237135 @default.
• W2945986988 cites W2808335286 @default.
• W2945986988 cites W2808436993 @default.
• W2945986988 cites W2808569466 @default.
• W2945986988 cites W2810336716 @default.
• W2945986988 cites W4211051919 @default.
• W2945986988 cites W4211203631 @default.
• W2945986988 cites W4211214771 @default.
• W2945986988 cites W4242472190 @default.
• W2945986988 doi "https://doi.org/10.1016/j.kint.2019.03.033" @default.
• W2945986988 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31352975" @default.
• W2945986988 hasPublicationYear "2019" @default.
• W2945986988 type Work @default.
• W2945986988 sameAs 2945986988 @default.
• W2945986988 citedByCount "50" @default.
• W2945986988 countsByYear W29459869882019 @default.
• W2945986988 countsByYear W29459869882020 @default.
• W2945986988 countsByYear W29459869882021 @default.

• next